RUN insider files Form 144 to sell 2,180 RSU shares via Charles Schwab
Rhea-AI Filing Summary
Sunrun Inc. (RUN) Form 144 shows a proposed sale of 2,180 common shares through Charles Schwab with an aggregate market value of $36,911, representing part of the holder's equity compensation. The shares were recorded as acquired by RSU lapse on 09/08/2025 and the proposed approximate sale date is 09/08/2025 on NASDAQ. The filing also discloses a prior sale by the same person on 07/07/2025 of 8,909 shares for gross proceeds of $96,261. The filing includes the required attestation that the seller is not aware of undisclosed material adverse information.
Positive
- Disclosed acquisition type shows the shares originated from RSU lapse, clarifying these are equity-compensation shares
- Broker and execution venue provided (Charles Schwab; NASDAQ), which supports transparent routing of the sale
- Prior sales reported for the required three-month lookback (8,909 shares on 07/07/2025), meeting disclosure obligations
Negative
- Insider sales reported (2,180 proposed plus 8,909 prior) reduce the holder's position and may be interpreted negatively by some investors
- No relationship to issuer specified in the visible fields, leaving the exact insider status or affiliation unclear
Insights
TL;DR: Routine insider disposition of equity-compensation shares; amounts are modest relative to public float.
This Form 144 documents a proposed sale of 2,180 common shares acquired via RSU lapse and a recent prior sale of 8,909 shares that generated $96,261. The transactions are processed through a major broker and scheduled for NASDAQ execution. The filing provides standard Rule 144 disclosure and the seller's attestation regarding material nonpublic information. Given the small absolute sizes relative to Sunrun's total outstanding shares, the direct market impact is likely limited.
TL;DR: Filing appears compliant with Rule 144 mechanics and includes required attestation; no regulatory red flags evident from the document.
The notice specifies acquisition type (RSU lapse), consideration (equity compensation), broker details, and prior sales in the three-month lookback, fulfilling Form 144 disclosure elements. The signature/attestation language is present, and there is no statement of undisclosed material adverse information. Documentation appears standard for an insider or related-party sale of vested equity awards.